Synergistic effects of longitudinal amyloid and vascular changes on lobar microbleeds

Yeo Jin Kim1, Hee Jin Kim1, Jae-Hyun Park1

  • 1From the Department of Neurology (Y.J.K.), Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon; Departments of Neurology (H.J.K., D.L.N., S.W.S.) and Nuclear Medicine (Y.S.C., K.-H.L., S.H.M.), Sungkyunkwan University School of Medicine, and Neuroscience Center (H.J.K., D.L.N., S.W.S.), Samsung Medical Center, Seoul; Department of Neurology (J.-H.P.), Semyeong Christianity Hospital, Pohang; Biostatistics Team (S.K., S.-Y.W.), Samsung Biomedical Research Institute; Department of Biomedical Engineering (K.-C.K., J.M.L.), Hanyang University, Seoul; Department of Neurology (N.-Y.J.), Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan; Departments of Nuclear Medicine (J.S.K.) and Neurology (J.-H.L.), University of Ulsan College of Medicine, Asan Medical Center, Seoul; Department of Neurology (Y.J.K.), Ilsong Institute of Life Science, Hallym University, Anyang, Korea; Stroke Research Centre (D.J.W.), Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Queen Square, London, UK; and Departments of Health Sciences and Technology (D.L.N.) and Clinical Research Design & Evaluation (S.W.S.), SAIHST, Sungkyunkwan University, Seoul, Korea.

Neurology
|September 16, 2016
PubMed
Abstract

Insights

Amyloid pathology and hypertensive cerebral small vessel disease (hCSVD) interact to worsen lobar microbleeds in mild cognitive impairment. This suggests combined strategies may be needed for prevention.

Area of Science:

  • Neurology
  • Neuroimaging
  • Gerontology

Background:

  • Subcortical vascular mild cognitive impairment (svMCI) is associated with amyloid and hypertensive cerebral small vessel disease (hCSVD).
  • The interplay between these pathologies in driving microbleed progression is not fully understood.

Purpose of the Study:

  • To investigate the synergistic effects of amyloid burden and hCSVD on the progression of lobar microbleeds in svMCI patients.
  • To explore the relationship between microbleed progression and cognitive decline.

Main Methods:

  • Longitudinal analysis of 72 svMCI patients over 3 years.
  • Utilized brain MRI and [11C] Pittsburgh compound B (PiB)-PET for amyloid imaging.
  • Assessed annual neuropsychological testing and MRI for microbleed and hCSVD changes.

Main Results:

  • Incident cerebral microbleeds (CMBs) occurred in 59.6% of patients.
  • Both lacune changes and PiB retention were linked to microbleed progression, particularly in lobar regions.
  • Amyloid and hCSVD showed synergistic effects on lobar microbleed progression and were associated with cognitive decline.

Conclusions:

  • Amyloid pathology and hCSVD synergistically accelerate lobar microbleed progression in svMCI.
  • Findings offer insights into the combined impact of amyloid and hCSVD on CMBs and cognitive decline.
  • Suggests potential for combined prevention strategies targeting both pathologies.